lexi
IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2833 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1DPP-4 inhibitors: a patent review (2012 – 2014)
Roberto Costante,Azzurra Stefanucci,Simone Carradori,Ettore Novellino,Adriano Mollica
Expert Opinion on Therapeutic Patents.2015;25(2)209
[DOI]
2Challenge of diabetes mellitus and researchers’ contributions to its control
Ayodele T. Odularu,Peter A. Ajibade
Open Chemistry.2021;19(1)614
[DOI]
3Sensitive detection of quinoline-derivatized sitagliptin in small volumes of human plasma by MALDI-TOF mass spectrometry
Yi-Shan Li,Wei-Lung Tseng,Chi-Yu Lu
Talanta.2020;218(1)121143
[DOI]
4In Vivo Efficacy of HD0471953: A Novel GPR119 Agonist for the Treatment of Type 2 Diabetes Mellitus
So Ra Kim,Dae-Hoon Kim,Soo Hyun Park,Young Seok Kim,Chun Hwa Kim,Tae-Young Ha,Jin Yang,Jae-Keol Rhee
Journal of Diabetes Research.2013;2013(1)1
[DOI]
5Erythrocyte mechanical fragility is increased in patients with type 2 diabetes
Giuseppe Lippi,Mariella Mercadanti,Rosalia Aloe,Giovanni Targher
European Journal of Internal Medicine.2012;23(2)150
[DOI]
6Dipeptidyl peptidase-4 inhibitors: Multitarget drugs, not only antidiabetes drugs (D ipeptidyl peptidase -4???:?????,???????)
Yunjuan Zhao,Lin Yang,Zhiguang Zhou
Journal of Diabetes.2014;6(1)21
[DOI]
7HD047703, a New Promising Anti-Diabetic Drug Candidate: In Vivo Preclinical Studies
SoRa Kim,Dae Hoon Kim,Young-Seok Kim,Tae-Young Ha,Jin Yang,Soo Hyun Park,Kwang Won Jeong,Jae-Keol Rhee
Biomolecules & Therapeutics.2014;22(5)400
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow